Stock Details
AZN is AstraZeneca PLC's stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 66.56$. Average daily volumn in 3 months 5.19M. Market cap 214.45B

Stock symbol : AZN. Exchange : NasdaqGS. Currency : USD
Lastest price : 69.18$. Total volume : 3.94M. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

AstraZeneca PLC (AZN)
Last Price

Previous Close68.64
Day Range68.64-69.22
Bid69.17 x 900
Ask69.18 x 900
Average Volume5.19M
Market Cap214.45B
52 Week Range52.65-72.12
Trailing P/E65.27
Foward P/E16.05
Dividend (Yield %)2.11%
Ex-Dividend Date2023-02-23

Financial Details

According to AstraZeneca PLC's financial reports the company's revenue in 2022 were 44.35B an increase( +18.92%) over the years 2021 revenue that were of 37.42B. In 2022 the company's total earnings were 3.29B while total earnings in 2021 were 112M( +2578.57%).

Loading ...


AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern,... Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Market Cap:
Total Assets:
Total Cash:

News about "AstraZeneca PLC"


AstraZeneca PLC ADR underperforms Tuesday when compared to competitors

Source from : MarketWatch - 2 days ago

The AstraZeneca PLC ADR shed 0.19% to $68.60 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ ...See details»

AstraZeneca Completes KYM Solid Tumors Treatment Deal

Source from : MarketWatch - 20 hours ago

By Michael Susin AstraZeneca PLC said Thursday that it has completed an exclusive global license agreement with KYM Biosciences over the CMG901 treatment ...See details»

Analyzing the Price-to-Earnings Ratio of AstraZeneca PLC (AZN)

Source from : newsheater - 2 days ago

The price-to-earnings ratio for AstraZeneca PLC (NASDAQ: AZN) is above average at 65.21x. The 36-month beta value for AZN is also noteworthy at 0.53. There are mixed opinions on the stock, with 21 ...See details»

AstraZeneca PLC (NASDAQ: AZN) Is Up 2.01% Year-To-Date, But Analysts Find Room For A Price Rally

Source from : stocksregister - 4 days ago

AstraZeneca PLC (NASDAQ:AZN) traded at $69.16 at last check on Monday, March 27, made an upward move of 1.84% on its previous day’s price. Looking at the stock we see that its previous close was ...See details»

Is AstraZeneca PLC (AZN) a Solid Prospective Investment?

Source from : Yahoo Finance - 10 days ago

Artisan Global Equity Fund highlighted stocks like AstraZeneca PLC (NASDAQ:AZN) in the Q4 2022 investor letter. Headquartered in Cambridge, the United Kingdom, AstraZeneca PLC (NASDAQ:AZN ...See details»

Is AstraZeneca PLC (AZN) a High Growth Stock?

Source from : Yahoo - 1 month ago

Baron Funds highlighted stocks like AstraZeneca PLC (NASDAQ:AZN) in the Q4 2022 investor letter. Headquartered in Cambridge, the United Kingdom, AstraZeneca PLC (NASDAQ:AZN) is a global ...See details»

AstraZeneca PLC (AZN) Shares Up Despite Recent Market Volatility

Source from : newsheater - 1 month ago

AstraZeneca PLC (NASDAQ: AZN)’s stock price has increased by 1.72 compared to its previous closing price of 65.61. Nevertheless, the company has seen a 2.39% surge in its stock price over the last ...See details»

astrazeneca plc

Source from : Fox Business - 7 days ago

AstraZeneca recorded a big jump in revenue on Thursday as it begins to take a profit from its coronavirus vaccine for the first time. Positive clinical trial results for Merck & Co's experimental ...See details»

Client Profile: AstraZeneca PLC

Source from : - 1 month ago

Alexion Pharmaceuticals $910,000 Katie Jones No Revolving Door Profiles Non Former Members of Congress AstraZeneca Pharmaceuticals $4,260,000 Susie Ahn Revolving Door Profiles Non Former Members of ...See details»


Source from : BBC - 1 days ago

Dearbail Jordan & Faisal Islam BBC business reporter & BBC economics editor AstraZeneca's Leif Johansson says AI and screening could prevent costly treatment in hospitals.See details»

AstraZeneca (AZN) Shares Cross Below 200 DMA

Source from : Nasdaq - 28 days ago

In trading on Thursday, shares of AstraZeneca plc (Symbol: AZN) crossed below their 200 day moving average of $64.26, changing hands as low as $64.25 per share. AstraZeneca plc shares are ...See details»

U.S. FDA panel to review expanded use of Merck-AstraZeneca's cancer drug

Source from : Yahoo News - 28 days ago

(Reuters) - Merck & Co Inc and British drugmaker AstraZeneca PLC said on Thursday that an independent committee of advisers to the U.S. health regulator will review the companies' application for the ...See details»

AstraZeneca PLC (AZN) Stock Historical Prices & Data - Yahoo Finance

Source from : Yahoo Finance - 2 years ago

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...See details»

AstraZeneca PLC ADR

Source from : Wall Street Journal - 1 year ago

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...See details»